Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Biaobo Xu"'
Autor:
Howard L. McLeod, Xi Li, Biaobo Xu, Yijing He, Wei Zhang, Ruizheng Liu, Ping Liao, Jamie K. Teer, Wei Li
Publikováno v:
OncoTargets and therapy
Ping Liao,1 Wei Li,1 Ruizheng Liu,2 Jamie K Teer,2 Biaobo Xu,3 Wei Zhang,1 Xi Li,1 Howard L Mcleod,1,2 Yijing He1,2 1Hunan Key Laboratory of Pharmacogenetics, Department of Clinical Pharmacology, Institute of Clinical Pharmacology, Xiangya Hospital,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66aef7ec16a566ac0cf199bc47f3d75c
http://europepmc.org/articles/PMC6199229
http://europepmc.org/articles/PMC6199229
Autor:
Zhengxiao Ouyang, Yi Luo, Xu Zhang, Todd C. Knepper, Xuezheng Xu, Liyang Zhang, Chengfang Zhou, Howard L. McLeod, Xianan Li, Ruo-Hui He, Weili Wang, Weiqi Zeng, Gang Huang, Yijing He, Xiang Chen, Jie Liu, Biaobo Xu, Cong Peng
Publikováno v:
Oncotarget
// Chengfang Zhou 1 , Xiang Chen 3 , Weiqi Zeng 3 , Cong Peng 3 , Gang Huang 4 , Xian’an Li 4 , Zhengxiao Ouyang 4 , Yi Luo 4 , Xuezheng Xu 4 , Biaobo Xu 1 , Weili Wang 1 , Ruohui He 1 , Xu Zhang 3 , Liyang Zhang 5 , Jie Liu 1 , Todd C. Knepper 2 ,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f4f6332834e932cfc9cc9497afc3456
https://doi.org/10.18632/oncotarget.11599
https://doi.org/10.18632/oncotarget.11599
Publikováno v:
Die Pharmazie. 71(8)
ABCG2, an efflux pump protein-BCRP coding gene, is involved in the acquisition of chemotherapeutic drug resistance. In recent years, the epigenetic regulation of ABCG2, such as DNA methylation, has become a research hotspot and been attracting widesp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a81b945d2468bc1b4f12cae857eb83f8
https://pubmed.ncbi.nlm.nih.gov/29442031
https://pubmed.ncbi.nlm.nih.gov/29442031
Autor:
Zirui Wan, Tai-Lin Li, Yan Peng, Qi Pei, Guo Wang, Yuan-Shan Zhu, Biaobo Xu, Hong Sun, Guoping Yang, Ying Zeng, Lijuan Cheng
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 354:310-315
Rosuvastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor used to lower blood low-density lipoprotein cholesterol, is a substrate of the membrane ABCG2 exporter. ABCG2 variants have been shown to alter rosuvastatin disposition. The ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8798950137bbf99135644c5878680beb
https://doi.org/10.1124/jpet.115.225045
https://doi.org/10.1124/jpet.115.225045
Autor:
Yijing He, Ping Liao, Wei Li, Biaobo Xu, Xianli Yin, Meizuo Zhong, Todd C. Knepper, Daniel M. Rotroff, Hua Shen, Chengfang Zhou, Weili Wang, Howard L. McLeod, Shangchen Xie
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 471
Background Epstein-Barr virus (EBV) and microsatellite instability (MSI) are associated with the carcinogenesis of many kinds of tumors, including gastric cancer (GC). However, the impact of EBV and MSI status on the prognosis of stage II and III GC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49af9a773d92816bee63b09fbe146d74
https://pubmed.ncbi.nlm.nih.gov/28601671
https://pubmed.ncbi.nlm.nih.gov/28601671